We found that knockdown of ATP1B1 accelerated endothelial cell proliferation and angiogenesis and that ATP1B1 inhibition with digoxin reduced liver fibrosis in NASH. This evidence concerns the gene ATP1B1 and metabolic dysfunction-associated steatohepatitis.